Osivax, a clinical stage biopharmaceutical company focused on innovative influenza vaccines, has partnered with GC Biopharma, a prominent South Korean
Category: Future of Life Sciences
The Evolution of Single-Use Technologies in Biopharmaceuticals
NVRO Metals Achieves Key Milestone in Continuous Production of the NVRO Process™
The Shift Towards Smartphone-Centric In-Car Software
What’s next for computational systems biology?
Charles River Labs and Medigen Vaccine Biologics: Pioneering Vaccine Development with Next-Generation Sequencing
Charles River Laboratories (CRL) and Medigen Vaccine Biologics Corp. (MVC) have entered a strategic partnership aimed at enhancing vaccine development






































